Substance Use Disorders and COVID-19 Vaccine Response
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:326 |
|---|---|
| Enthalten in: |
JAMA - 326(2021), 20 vom: 23. Nov., Seite 2000 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Rubin, Rita [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 30.11.2021 published: Print Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1001/jama.2021.19977 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM333501519 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM333501519 | ||
| 003 | DE-627 | ||
| 005 | 20231225221758.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1001/jama.2021.19977 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1111.xml |
| 035 | |a (DE-627)NLM333501519 | ||
| 035 | |a (NLM)34812881 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Rubin, Rita |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Substance Use Disorders and COVID-19 Vaccine Response |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 30.11.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 773 | 0 | 8 | |i Enthalten in |t JAMA |d 1948 |g 326(2021), 20 vom: 23. Nov., Seite 2000 |w (DE-627)NLM000006939 |x 1538-3598 |7 nnns |
| 773 | 1 | 8 | |g volume:326 |g year:2021 |g number:20 |g day:23 |g month:11 |g pages:2000 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1001/jama.2021.19977 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 326 |j 2021 |e 20 |b 23 |c 11 |h 2000 | ||